文献速递眼底病与葡萄膜炎

无视网膜病变糖尿病患者脉络膜与神经退行性变化的3年前瞻性研究

Rates of Choroidal and Neurodegenerative Changes Over Time in Diabetic Patients Without Retinopathy: A 3-Year Prospective Study.
PubMed 文献 · Am J Ophthalmol · 2022-07-20

该研究为前瞻性观察性队列研究,纳入广州社区登记的2型糖尿病患者924例,每年进行扫频源光学相干断层扫描,随访3年。结果显示159例(17.2%)发生糖尿病视网膜病变(IDR),IDR组脉络膜厚度(CT)和黄斑区神经节细胞-内丛状层(GC-IPL)变薄速度显著快于未发生DR(NDR)组,但两组均观察到厚度下降。

要点

  • 3年随访中,924例糖尿病患者中159例(17.2%)发生糖尿病视网膜病变。
  • IDR组CT年均下降-6.98 μm/y,NDR组-3.98 μm/y,差异有统计学意义(P < .001)。
  • 校正混杂因素后,IDR组CT和GC-IPL变薄分别比NDR组快2.09 μm/y和-0.29 μm/y(P = .004)。

核心结论

  • 在3年随访期间,发生糖尿病视网膜病变的眼睛与未发生者的视网膜神经退行性变和脉络膜变薄速率存在显著差异,但两组均观察到厚度下降。
  • 这表明GC-IPL和脉络膜厚度可能在糖尿病视网膜病变临床表现出现之前就已下降。

研究设计与样本

  • 前瞻性观察性队列研究,从广州社区登记处招募2型糖尿病患者,最终纳入924例进行分析。
  • 所有参与者每年接受扫频源光学相干断层扫描,测量脉络膜厚度(CT)、视网膜厚度(RT)和神经节细胞-内丛状层(GC-IPL)厚度,随访3年。
  • 比较发生糖尿病视网膜病变(IDR)与保持无糖尿病视网膜病变(NDR)患者之间GC-IPL、CT和RT的变化。

主要发现

  • 924例患者中159例(17.2%)在3年随访内发生糖尿病视网膜病变(IDR)。
  • NDR组和IDR组均观察到GC-IPL、RT和CT下降;IDR组CT变薄显著加速,IDR组平均CT下降-6.98 μm/y(95% CI:-8.26,-5.71),NDR组为-3.98 μm/y(95% CI:-4.60,-3.36),P < .001。
  • 3年内平均GC-IPL厚度下降:IDR组-0.97 μm/y(95% CI:-1.24,-0.70),NDR组-0.76 μm/y(95% CI:-0.82,-0.70),P = .025。
  • 校正混杂因素后,IDR组平均CT变薄比NDR组快2.09 μm/y(95% CI:1.01,3.16;P = .004),平均GC-IPL变薄快-0.29 μm/y(95% CI:-0.49,-0.09;P = .004)。
  • IDR组RT随时间增加而NDR组RT随时间下降,中央区RT的校正差异为2.09 μm/y(95% CI:1.01,3.16;P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the longitudinal changes of retinal neurodegeneration and choroidal thickness in diabetic patients with and without diabetic retinopathy (DR). DESIGN: Prospective observational cohort study. METHODS: This prospective observational cohort study recruited type 2 diabetic patients from a community registry in Guangzhou. All participants underwent annual ocular examinations via swept-source optical coherence tomography that obtained choroid thickness (CT), retinal thickness (RT), and ganglion cell-inner plexiform layer (GC-IPL) thickness. The changes in GC-IPL, CT, and RT between patients who developed incident DR (IDR) or remained non-DR (NDR) were compared during a 3-year follow-up. RESULTS: Among 924 patients, 159 (17.2%) patients developed IDR within the 3-year follow-up. A reduction in GC-IPL, RT, and CT was observed in NDR and IDR; however, CT thinning in patients with IDR was significantly accelerated, with an average CT reduction of -6.98 (95% CI: -8.26, -5.71) μm/y in patients with IDR and -3.98 (95% CI: -4.60, -3.36) μm/y in NDR patients (P < .001). Reductions in average GC-IPL thickness over 3 years were -0.97 (95% CI: -1.24, -0.70) μm/y in patients with IDR and -0.76 (95% CI: -0.82, -0.70) μm/y in NDR patients (P = .025). After adjusting for confounding factors, the average CT and GC-IPL thinning were significantly faster in patients with IDR compared with those who remained NDR by 2.09 μm/y (95% CI: 1.01, 3.16; P = .004) and -0.29 μm/y (95% CI: -0.49, -0.09; P = .004), respectively. The RT in the IDR group increased, whereas the RT in the NDR group decreased over time, with the adjusted difference of 2.09 μm/y (95% CI: 1.01, 3.16; P < .001) for central field RT. CONCLUSIONS: The rate of retinal neurodegeneration and CT thinning were significantly different between the eyes that developed IDR and remained NDR during the 3-year follow-up, but both groups observed thickness reduction. This indicates that GC-IPL and CTs may decrease before the clinical manifestations of DR.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Huang Y, Zhang N, Bulloch G, et al. Rates of Choroidal and Neurodegenerative Changes Over Time in Diabetic Patients Without Retinopathy: A 3-Year Prospective Study. Am J Ophthalmol. 2022. PMID: 35870490. doi:10.1016/j.ajo.2022.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。